Novo Nordisk A/S
XMUN:NOV
Wall Street
Price Targets
NOV Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for
NOV
is 49.214 EUR
with a low forecast of 35.83 EUR and a high forecast of 75.905 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NOV's stock price target?
Price Target
49.214
EUR
According to Wall Street analysts, the average 1-year price target for
NOV
is 49.214 EUR
with a low forecast of 35.83 EUR and a high forecast of 75.905 EUR.
What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
3%
For the last 14 years the
compound annual growth rate for
Novo Nordisk A/S's revenue is
12%.
The projected
CAGR
for the next 3 years is
3%.
What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Novo Nordisk A/S's operating income is
13%.
The projected
CAGR
for the next 3 years is
8%.
What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Novo Nordisk A/S's net income is
14%.
The projected
CAGR
for the next 3 years is
7%.
